This study determined the effect of long-term administration of 4 G -␤ -D -galactosylsucrose (lactosucrose; LS) on intestinal calcium absorption. In a randomized, singleblind, parallel-group study, LS ( n ϭ 9, 6.0 g twice daily) or a placebo (maltose; n ϭ 8, 6.0 g twice daily) was administered to healthy young women for 92 wk; the study also included a 4-wk post-administration period. All participants completed the study. Dietary nutrient intake; fecal weight, pH, and moisture content; fecal concentrations of short-chain fatty acids (SCFA), putrefactive products, ammonia, and minerals (calcium, magnesium, phosphorus, and iron); and serum calcium and osteocalcin concentrations were measured every 24 wk. Urinary pyridinoline (PYR) and deoxypyridinoline (DPD), and urinary calcium excretion were measured every 12 wk. Significant effects of oligosaccharide treatment, time, and the interaction between oligosaccharide treatment and time were observed for fecal pH, SCFA, ammonia, and putrefactive product values ( p Ͻ 0.05). Fecal pH, ammonia, and putrefactive product values decreased in the LS group, and the fecal SCFA concentration significantly increased during the administration period; these changes were not observed 4 wk post-administration. To examine the mineral balance of calcium, magnesium, and phosphorus in detail, all the participants completed a 6-d mineral balance study, sometime between week 56 and 60 of the longer study. During the mineral balance study, the daily calcium intake was set at 400 mg; all feces and urine were collected each day for 6 d after an 8-d acclimation period. In the balance study, fecal calcium excretion was significantly lower in the LS group than in the placebo group ( p Ͻ 0.05), and apparent calcium absorption and retention, apparent magnesium and phosphorus absorption, and magnesium retention were significantly higher in the LS group than in the placebo group ( p Ͻ 0.05). Our results suggest that the administration of LS produces a long-term enhancement of intestinal calcium absorption in healthy young women with lower than recommended calcium intakes. Key Words fecal pH, fecal short-chain fatty acids, intestinal calcium absorption, lactosucrose, young healthy women Calcium is an essential component of bone, and insufficient calcium intake may cause weakened bones, especially in women who are prone to osteoporosis. Bone mass in later life depends on the peak bone mass (PBM) achieved during growth and the rate of subsequent age-related bone loss ( 1 ). Bone mineral is laid down throughout childhood, with the most rapid increase occurring during puberty. The deposition continues, though at a slower rate, after growth in height has stopped ( 2 ). PBM is achieved in early adult life (20-35 y of age), although the exact timing is not certain and may vary in different parts of the skeleton ( 3 ). The calcium intake in young Japanese women is lower than the recommended calcium intake ( 4 -6 ). Thus, these women are at risk of future osteoporosis resulting from insufficient calcium intake. Moreover, many young Japanese women are inclined to diet by skipping meals and/or restricting their eating ( 6 ), which may further decrease calcium intake.
absorption. Oral administration of NOD enhances intestinal calcium absorption in humans; this effect has been observed after a single dose of difructose anhydride III (DFA III) in healthy young men ( 10 ) and after the administration of either 9 wk of transgalactooligosaccharides ( 11 ) or 9 d of oligofructose in adolescents ( 12 ) . Several hypotheses have been advanced to explain the potential positive effect of NOD on intestinal mineral absorption in animals. Colonic fermentation of NOD leads to the formation of high concentrations of shortchain fatty acids (SCFA) and the presence of Ca 2 ϩ and Mg 2 ϩ in the colonic lumen ( 13, 14) . In addition, it has been hypothesized that NOD stimulate transcellular calcium absorption by a direct effect of the SCFA that are produced (15, 16) . Calbindin plays an important role in the intracellular diffusion rate of the calcium ion (17) , and the amount of calbindin has been found to be increased in both cecal and colorectal segments in gastrectomized rats fed fructooligosaccharides (18) . In addition, Suzuki and Hara reported that nondigestible saccharides open a paracellular calcium transport pathway in human intestinal Caco-2 cells (19) . Thus, these fermentation-induced changes would improve the intestinal absorption of various minerals.
Lactosucrose (LS) is an indigestible oligosaccharide synthesized from sucrose and lactose by Arthrobacter sp. K-1 ␤-fructofuranosidase (␤-D-fructofuranoside fructohydrolase, EC 3.2.1.26) (20) . Dietary supplementation with LS for 8 wk decreased fecal pH and increased the fecal concentration of SCFA in humans (21) . There are reports that a single administration (22) and 2-wk administration (23) of LS enhanced intestinal calcium absorption in healthy men. However, the reported period during which LS and other oligosaccharides were administered has only been several weeks at most. Previous research has not established whether the effect of LS on calcium absorption is transient or lasts long enough for long-term calcium deposition to occur. Therefore, the aim of the present study was to test whether the long-term administration of LS can enhance intestinal calcium absorption in healthy young women with slightly insufficient calcium intake.
PARTICIPANTS AND METHODS
Participants. Seventeen female students at Kawasaki University of Medical Welfare were recruited for this study. The anthropometric measurements of the participants are shown in Table 1 . The nature, purpose, and procedures of the study were fully explained to the participants by an independent medical doctor in accordance with the Helsinki Declaration, and the study was approved by the Ethics Committee of the Kawasaki University of Medical Welfare. Informed written consent was obtained from all participants before beginning the study.
Study design. A randomized, single-blind, placebocontrolled parallel design was employed. Participants orally consumed 12.0 g of LS (2.8% moisture, 56.4% LS, 22.2% sucrose, 6.9% lactose, 5.2% glucose, and 6.5% other oligosaccharides, 6.0 g twice daily; Ensuiko Sugar Refining Co., Ltd., Japan) or 12.0 g of maltose, which is digestible and has a similar structure (placebo, 6.0 g twice daily; Sanwa Cornstarch Co., Ltd., Japan), supplied as packets of powder for 92 wk. Neither the intake time nor the method was specified except for the balance study. The participants were asked to mark questionnaires daily to indicate that they had consumed the assigned supplement, and their consumption of the supplement was checked every week. The participants were advised to continue their habitual diets and maintain their usual physical activity throughout the experimental period, except during the balance study.
Dietary assessment. The participants learned to use a food weighing method (24) before the start of the study and were asked to weigh and record all foods and drinks consumed during 3 d of every 4 wk. Nutrient intakes were calculated according to the Standard  Tables of Food Composition in Japan (5th ed. ; 25) . The participants completed a lifestyle questionnaire that included questions about health status, lifestyle habits, frequency of defecation, and the properties of their feces. From this questionnaire, information about the number of bowel movements per week was obtained.
Feces, urine, anthropometric measurements, BMD, and blood collection. Feces were obtained 0, 24, 48, 72, and 92 wk after the beginning of the administration of LS or 
. Peripheral blood was drawn following the anthropometric measurements, after fasting overnight.
Balance study. To determine the effect of LS on mineral (calcium, magnesium, and phosphorus) absorption, the mineral balance was calculated in all participants. All the participants completed a 6-d balance study started after an 8-d equilibration period. The equilibration period started on the first day of menstruation occurring between week 56 and 60 of the main study. During the equilibration period and balance study, the participants consumed supplied food only and were asked to not consume products containing pre-or probiotics. The diets, which were supplied by Kawasaki Medical University, consisted of a 3-d cycle menu that was controlled for calcium (400 mg/d), energy (134 kJ/kg body weight/d), protein (1.08 g/kg body weight/d), dietary fiber (9.5 g/d), and vitamin D (300 IU/d). During the equilibration period, the women consumed the supplied diets for breakfast and dinner at home and for lunch at the university. LS or maltose was taken with breakfast and dinner. During the balance study, the women consumed the supplied diets at Kawasaki University of Medical Welfare, where 24-h urine and feces were collected for each of the 6 d. The participants ingested a dye to color their feces (Carmine 0.5 g) just before breakfast in the morning at the beginning and end of the 6 d. The actual food intake was determined by measuring the amount of food left uneaten. The participants had free access to barley tea. The amount of barley tea consumed was recorded at the university. The apparent absorption and retention were calculated by the following formulae:
Analyses
Urinary analysis: Urinary concentrations of calcium, magnesium, and iron were measured directly using an inductively coupled plasma-atomic emission spectrometer (5100PC; Perkin-Elmer Instruments, CT, USA) ( 26 ) . Urinary total pyridinoline (PYR) and total deoxypyridinoline (DPD) were determined by HPLC ( 27 ) . The amount of urinary creatinine was measured using an enzymatic colorimetric assay kit (Determiner L CRE; Kyowa Medix, Japan). The values are expressed as nmol per mmol urinary creatinine. The amount of urinary phosphorus was measured using an enzymatic colorimetric assay kit (Determiner L IP; Kyowa Medix).
Fecal analysis: The fecal calcium, magnesium, and iron contents were measured using an inductively coupled plasma-atomic emission spectrometer (PerkinElmer Instruments) ( 26 ) after digestion by the method of Husdan and Rapoport ( 28 ) . The fecal phosphorus content was determined using a phosphate assay kit (Determiner L IP; Kyowa Medix). Fecal moisture, pH, putrefactive products (indole, skatole, phenol, p -cresol, and 4-ethylphenol), SCFA (acetic, propionic, and nbutyric acids), other organic acids (lactic, succinic, formic, and n -valeric acids), and ammonia were measured as previously described ( 29 ) .
Blood analysis: Serum osteocalcin was measured by an immunoradiometric assay (Nichols Institute Diagnostics, CA, USA). Serum total cholesterol, triacylglycerol, glucose, aspartate aminotransferase, and alanine aminotransferase were assayed by enzymatic and colorimetric methods, using assay kits (Determiner TC 555, Determiner TG 555, Determiner GL-E, Determiner ALT, and Determiner AST, respectively; Kyowa Medix). Serum calcium concentration was determined using Calcium E-test (Wako Pure Chemical Industries, Ltd., Japan).
BMD: BMD was measured at the spine (L2-L4, anteroposterior direction) using dual energy X-ray absorptiometry (DXA; QDR-2000; Hologic, MA, USA) ( 30 ) by the same X-ray technician.
Measurement of minerals in the balance study. The diets were completely mixed and homogenized. Feces were also mixed and homogenized each day. Calcium and magnesium in these samples were measured with an inductively coupled plasma emission spectrophotometer ( 26 ) after digestion by the method of Husdan and Rapoport ( 28 ) . The phosphorus content was determined using a phosphate assay kit (Kyowa Medix). Calcium and magnesium in barley tea and urine were directly measured with an inductively coupled plasma emission spectrophotometer ( 26 ) . Fecal pH was measured as previously described ( 29 ) . The barley tea minerals were added to the dietary mineral intake.
Statistical analysis. The data are expressed as the mean Ϯ SD. All statistical analyses were performed using SPSS version 6.0 (SPSS Inc., Japan). The means of anthropometric measurements, dietary mineral intake, fecal variables, mineral excretion, urinary variables, and serum variables were compared by Tukey-Kramer post hoc comparison after preliminary two-way analysis of variance (ANOVA), using oligosaccharide treatment and time of experiment as factors. The associations between fecal calcium excretion and fecal variables (pH, SCFA, ammonia, and putrefactive products) and between fecal mineral excretion and fecal pH in the balance study were tested by Pearson's correlation. Differences between means with p Ͻ 0.05 were considered significant.
RESULTS

Participant characteristics and dietary nutrient intake
All participants completed this study. The intake rate of LS or maltose and response rates of the questionnaire throughout the experimental period were over 90%. Anthropometric measurements did not vary between the LS and maltose groups. BMD did not differ between the LS and maltose groups at 96 wk ( Table 1 ). The average daily nutrient intake at all time points did not differ between the LS and maltose groups ( Table 2 ). The average dietary intake of calcium, magnesium, phosphorus, and iron for each time point did not differ significantly between groups or among different experimental weeks; no significant interaction effects were observed (Table 3 ). Daily intake of minerals and other nutrients for women in both groups was similar throughout the experimental period. No significant one-way or interaction effects existed for serum cholesterol, triacylglycerol, glucose, aspartate aminotransferase, or alanine aminotransferase, and all values were within the normal ranges. Number of bowel movements and fecal weight, moisture, pH, SCFA, other organic acids, ammonia, and putrefactive products (Table 4) No significant one-way or interaction effects existed for fecal weight, fecal moisture, and number of bowel movements. A significant two-way interaction effect existed for pH, SCFA, propionic acid, n -butyric acid, ammonia, and putrefactive products. The fecal pH and ammonia were lower in the LS group during the administration period (24, 48, 72 , and 92 wk; p Ͻ 0.05) but not at 0 and 96 wk. The fecal SCFA and n -butyric acid concentrations were both higher in the LS group than in the maltose group at 48 and 72 wk ( p Ͻ 0.05 for each), and the fecal propionic acid concentration was higher in the LS group at 48 and 92 wk ( p Ͻ 0.05). Putrefactive product concentration was lower in the LS group than in the maltose group at 24, 48, and 72 wk ( p Ͻ 0.05). Significant oligosaccharide treatment effects were observed for acetic acid and n -valeric acid ( p Ͻ 0.05). Fecal acetic acid and n -valeric acid concentrations were high in the LS group throughout the administration period. Fecal mineral excretion (Table 5) Changes in fecal calcium, magnesium, iron, and phosphorus excretion are shown in Table 5 . No significant two-way interaction effect was present for fecal magnesium, phosphorus, or iron excretion, but there was a trend toward an interaction for fecal calcium excretion ( p ϭ 0.10). Significant oligosaccharide treatment and time effects were observed for fecal calcium and phosphorus excretion ( p Ͻ 0.05), a significant oligosaccharide treatment effect was observed for fecal magnesium excretion ( p Ͻ 0.05), and a significant time effect was observed for fecal iron excretion ( p Ͻ 0.05). The fecal calcium, magnesium, and phosphorus excre- The changes in urinary PYR and DPD, and urinary calcium excretion are shown in Fig. 1 . A significant two-way interaction effect did not exist, but significant oligosaccharide treatment and time effects were observed for both PYR and DPD ( p Ͻ 0.05). The PYR and DPD levels were less in the LS group than in the maltose group ( p Ͻ 0.05). The PYR level at 92 wk was significantly less than at 12, 24, 48, 60, and 72 wk ( p Ͻ 0.05); and that at 96 wk was less than at 12, 48, 60, and 72 wk ( p Ͻ 0.05). The DPD level at 92 wk was less than that at 0, 12, 60, and 72 wk; that at 24 and 48 wk was less than that at 60 wk; and that at 96 wk was less than at 60 wk ( p Ͻ 0.05). No significant oneway or interaction effects existed for urinary calcium excretion. The changes in serum calcium and osteocalcin concentrations are shown in Table 6 . There were no significant effects of oligosaccharide treatment, time, or their interaction on serum calcium concentration, whereas significant oligosaccharide and time effects were observed for serum osteocalcin concentration ( p Ͻ 0.05). 1 Results are expressed as means Ϯ SD; n ϭ 9 (LS), n ϭ 8 (maltose). Significant main effects of oligosaccharide treatment (O) or time (T), or of the O ϫ T interaction, p Ͻ 0.05.
Fig. 1. Urinary pyridinoline (PYR) and deoxypyridinoline (DPD)
, and urinary calcium excretion in healthy young women consuming lactosucrose (LS) or maltose (placebo) for 92 wk. Urine was collected for 24 h on three consecutive days at each time point. PYR and DPD were standardized using the creatinine concentration. Values are means Ϯ SD; n ϭ 9 (LS), n ϭ 8 (maltose). Significant main effects of oligosaccharide treatment (O) or time (T) or of the O ϫ T interaction, p Ͻ 0.05. The PYR and DPD levels were less in the LS group than in the maltose group ( p Ͻ 0.05). The PYR level at 92 wk was less than that at 12, 24, 48, 60, and 72 wk; and that at 96 wk was less than that at 12, 48, 60, and 72 wk ( p Ͻ 0.05). The DPD level at 92 wk was less than that at 0, 12, 60, and 72 wk; that at 24 and 48 wk was less than that at 60 wk; and that at 96 wk was less than that at 60 wk ( p Ͻ 0.05). Means in a row with superscripts not sharing a letter differ, p Ͻ 0.05. No significant one-way or interaction effects existed for urinary calcium excretion. 
Mineral balance study
To determine the effect of LS on mineral (calcium, magnesium, and phosphorus) absorption, the mineral balance was calculated in all participants halfway through the experimental period. The fecal pH of the LS group in the mineral balance study (6.12 Ϯ 0.38) was lower than that of the maltose group (6.65 Ϯ 0.22; p Ͻ 0.05). Dietary calcium intake from the cycle menu in the mineral balance study did not differ between the LS and maltose groups, but dietary magnesium and phosphorus intake was higher in the LS group ( p Ͻ 0.05; Table 7 ). Fecal calcium excretion was lower in the LS group than in the maltose group ( p Ͻ 0.05), whereas fecal magnesium and phosphorus excretion did not differ. Although urinary calcium excretion did not differ between the two groups, urinary magnesium and phosphorus excretion was higher in the LS group than in the maltose group ( p Ͻ 0.05). Apparent calcium, magnesium, and phosphorus absorption was higher in the LS group than in the maltose group ( p Ͻ 0.05). Calcium and magnesium retention was higher in the LS group than in the maltose group ( p Ͻ 0.05); the phosphorus Table 7 . Fecal and urinary mineral excretion, apparent absorption, and retention during a mineral balance study in healthy young women. 1 Results are expressed as means Ϯ SD; n ϭ 9 (LS), n ϭ 8 (maltose). All women participated in the balance study between week 56 and week 60 of the administration period. * Different from the maltose group, p Ͻ 0.05. retention did not differ between the two groups.
Correlation analyses
The correlations between fecal calcium excretion and the fecal variables (pH, SCFA, ammonia, and putrefactive products) for all measurements and the correlations between fecal mineral (calcium, magnesium, and phosphorus) excretion, apparent absorption and retention, and fecal pH in the balance study are shown in Table 8 . Fecal calcium excretion for all measurements was correlated with fecal pH, SCFA, and putrefactive products ( p Ͻ 0.05). Only the LS group showed a significant correlation between fecal calcium excretion for all measurements and pH, SCFA, and putrefactive products. No significant correlation was observed between fecal calcium excretion for all measurements and fecal ammonia. In the mineral balance study, fecal calcium and magnesium excretion; apparent calcium, magnesium, and phosphorus absorption; and calcium and magnesium retention were correlated with fecal pH ( p Ͻ 0.05) in all participants. However, only the LS group showed significant correlations between calcium and magnesium excretion and apparent absorption ( p Ͻ 0.05), and calcium and magnesium retention tended to correlate with fecal pH (calcium, p ϭ 0.095; magnesium, p ϭ 0.12).
DISCUSSION
In this study, we investigated the effects of long-term administration of LS on intestinal calcium absorption in healthy female university students in Japan. The average dietary calcium intake in this study measured at each time point (503 mg/d) was lower than the tentative dietary goal for preventing lifestyle-related disease (600 mg/d) recommended in 2005 by the Ministry of Health, Labour and Welfare of Japan ( 31 ) . In this study, the intake of foodstuffs and supplements was not strictly controlled, except during the balance study, to allow the investigation to be performed without changing the lifestyles and daily activities of the participants. Nevertheless, there was no between-group difference in the dietary intake of minerals or other nutrients (Tables 2  and 3 ). This finding indicates that the significant between-group variances in mineral balance and other parameters were the result of the administration of LS and not due to differences in diet.
This study showed that the administration of LS produced significant decreases in pH, ammonia, and putrefactive products and increased SCFA during the administration period as previously described ( 21 , 29 ) . There is no report that the oligosaccharides maintained decreased levels of pH, ammonia, and putrefactive products or increased SCFA for 92 wk in young healthy women. These phenomena disappeared within 4 wk of discontinuing administration (Table 4) . LS administration tended to decrease the calcium excretion in feces. In addition, LS administration enhanced the apparent absorption of magnesium and phosphorus in the mineral balance study (Table 7) . Fecal calcium excretion was positively correlated with fecal pH, SCFA, and putrefactive products, whereas the apparent absorption and retention were negatively correlated with fecal pH (Table 8) . Therefore, we postulated that the effect of LS on intestinal calcium absorption is due to changes in the luminal environment.
To investigate calcium absorption in detail, we examined the mineral (calcium, magnesium, and phosphorus) balance in all participants. In this study, the dietary calcium intake was lower than recommended ( 31 ) . There are reports that 2-mo calcium supplementation in postmenopausal women decreased bone resorption markers when the dietary calcium intake was low ( 32 , 33 ) . A 21-d high dietary calcium intake in adolescents increased intestinal calcium absorption and decreased bone resorption ( 8 ) . We considered the effect of dietary calcium on intestinal calcium absorption for women whose dietary calcium intake was lower than average, and we set the dietary calcium level to near the lower boundary value (400 mg/d) in the balance study based on the results of the dietary calcium intake. The participants were not required to eat the entire meal and had free access to barley tea containing 0.002% calcium. The significant difference in the intake of magnesium and phosphorus in the balance study was probably the result of differences in the amounts consumed. As a result, our mineral balance study showed that LS administration decreased fecal calcium excretion and increased apparent calcium absorption and calcium retention (Table 7) . Our results should be interpreted as indicating that LS improved the calcium balance in healthy young women with lower-than-recommended calcium intakes by increasing intestinal calcium absorption.
The iron intake in young Japanese women is lower than the recommended iron intake ( 31 ), as was the case in this study. We also investigated fecal iron excretion. However, LS administration did not change the iron excretion in feces (Table 5) .
Chronic calcium deficiency resulting from inadequate intake or poor intestinal absorption often causes reduced bone mass and osteoporosis ( 1 ). It is vital, therefore, that adequate dietary calcium be consumed at all stages of life so that the genetically programmed PBM can be reached, skeletal mass can be maintained, and age-related bone loss can be minimized. Bone resorption and formation in young adulthood continue at a slower rate than during adolescence, and the consolidation of bone continues into young adulthood to the age of approximately 30 y ( 3 , 34 ) . In a report that investigated which bone densitometry and skeletal site were clinically useful for monitoring bone mass, spinal DXA was considered the most useful monitoring method for osteoporosis ( 35 ) . Bonjour et al. ( 36 ) and Cadogan et al. ( 37 ) reported that calcium supplementations given children and adolescents, typically of 1 to 2 y in duration, have shown that increased calcium intake is associated with a higher accrual rate of bone mass, depending on the skeletal site. In contrast, studies of calcium supplementation in postmenopausal women, typically of 1 to 2 y in duration, have shown that calcium cannot prevent bone loss, but can reduce the rate of bone loss to some extent ( 1 ). Calcium supplementation results in increased urinary calcium excretion with a reduction of PYR and DPD in postmenopausal women ( 33 ) . In our study, the BMD of the lumbar spine did not differ between the LS and maltose groups at 96 wk, and the BMD of the lumbar spine in the LS group did not change compared to week 0 ( Table  1) . The PYR and DPD levels were less in the LS group than in the maltose group. The serum osteocalcin concentration and urinary PYR and DPD excretion in all of the participants were within the normal range throughout the experimental period. In addition, urinary calcium excretion did not differ between groups (Fig. 1) . The apparent calcium absorption and retention were enhanced by LS administration, but retention was negative in the mineral balance study (Table 7) . We hypothesize that insufficient calcium intake might have been the reason for no change in the BMD of the lumbar spine and urinary calcium excretion. Our results suggest that it is desirable for young women to intake adequate dietary calcium to maintain bone health, as Cashman reported ( 1 ).
As an inorganic element, phosphorus is second to calcium in abundance in the human body, with 85% of the phosphorus in the body bound to the skeleton. Although phosphorus is an essential nutrient, there is concern that excessive amounts may be detrimental to bone. A rise in dietary phosphorus increases the serum phosphorus concentration, producing a transient fall in serum-ionized calcium, resulting in elevated parathyroid hormone (PTH) secretion and potentially in bone resorption ( 38 ) . Martinez et al. postulated that phosphorus homeostasis is modulated by vitamin D ( 39 ). In addition, Takeda et al. reported that the proper ratio of calcium to phosphorus in the diet is important for mineral mobilization and bone mineralization ( 40 ) . In our mineral balance study, LS administration enhanced apparent phosphorus absorption. However, the serum phosphorus concentration was within the normal range throughout the experimental period (data not shown). The lack of change in BMD might have been influenced by enhanced intestinal phosphorus absorption as a consequence of the enhanced intestinal calcium absorption during LS administration. Intestinal calcium absorption does not necessarily reflect its bioavailability to the whole organism, because some calcium must be retained and used in bone formation and mineralization. In addition, bone health depends on a range of other nutrients and foods as well as on environmental factors (41) . The insufficient calcium intake, age of the participants, ratio of calcium to phosphorus in the diet, and changes in LS administration may have influenced BMD. Thus, further study is needed to clarify the effects of LS on intestinal mineral absorption, bone remodeling markers, and BMD.
In summary, dietary administration of LS resulted in decreased fecal pH, ammonia, and putrefactive product concentrations; fecal calcium excretion; and urinary PYR and DPD excretion; and increased SCFA concentration in healthy young women during the administration period. LS administration also enhanced the intestinal absorption of calcium, magnesium, and phosphorus. Fecal calcium excretion was correlated with fecal pH, SCFA, and putrefactive products, indicating that the effect of LS on intestinal calcium absorption was attributable to changes in the luminal environment. The fecal calcium and magnesium excretion and apparent calcium and magnesium absorption were strongly correlated with fecal pH. Our results suggest that the administration of LS has a long-term effect that enhances intestinal calcium absorption and reduces bone resorption without changing BMD in healthy young women with lower than recommended calcium intake.
